CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- 4 Open-market sale SVP, Chief Scientific Officer sold 25,000 shares at $4.97 ($124,250)
- 4 Open-market sale SVP, Chief Medical Officer sold 15,968 shares at $4.68 ($74,730)
- 4 Shares withheld for taxes Chief Business Officer gave up 1,724 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 1,149 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 7,534 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Medical Officer gave up 9,032 shares (to pay taxes)
- 4 Grant or award Director acquired 4,610 shares (grant or award)
- 4 Grant or award Director acquired 4,610 shares (grant or award)
- 4 Grant or award Director acquired 4,610 shares (grant or award)
- 4 Grant or award Director acquired 4,610 shares (grant or award)
- 4 Grant or award Director acquired 4,610 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 15,000 shares (grant or award)
- 4 Grant or award SVP, Chief Medical Officer acquired 108,000 shares (grant or award)
- 4 Grant or award SVP, Chief Commercial Officer acquired 16,000 shares (grant or award)
- 4 Grant or award SVP, Chief Scientific Officer acquired 19,000 shares (grant or award)
- 4 Grant or award Chairman & CEO acquired 165,500 shares (grant or award)
- 4 Grant or award SVP, Chief Financial Officer acquired 96,500 shares (grant or award)
- 4 Grant or award VP of Business Dev't acquired 10,000 shares (grant or award)
- 4 Open-market sale 10% owner sold 500,000 shares at an average $5.58 ($2,791,290)
- 4 Open-market sale Former 10% holder sold 175,000 shares at $25.30 ($4,427,500)
Page 6 of 9 · 180 filings